Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy

Exclusion Criteria

• •1. Prior use of glucose lowering medication in the 3 months prior to screening.
• •2. A fasting glucose ≥ 126mg/dl or an HbA1c ≥ 6.5% will be taken as evidence of type 2 diabetes and therefore patients will be deemed ineligible for participation.
• •3. Prior abdominal surgery other than cholecystectomy, appendectomy or hysterectomy.
• •4. Pregnancy or active consideration of pregnancy during the period of study. Subjects will be discontinued if they become pregnant during the study.
• •5. Hypersensitivity to liraglutide or any product components.
• •6. Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2.
• •7. Prior history of pancreatitis, cholelithiasis or cholecystitis.
• •8. Concurrent use of insulin or any other GLP-1 receptor agonist.
• •9. Active, severe psychiatric disease